EIF4EBP1 and Miyoshi myopathy: Globally, 44 out 70 (62.8%) MM patients stained positive for p-mTOR and 37 (52.8%), 42 (60%) and 38 (54.3%) cases stained positive for p–AKT, p-P706SK and p-4E-BP1, respectively.